• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟羧氧酰胺菌素在血清、骨骼、组织液和腹水中的分布。

Distribution of moxalactam in serum, bone, tissue fluid, and peritoneal fluid.

作者信息

Wittmann D H, Schassan H H

出版信息

Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S610-6. doi: 10.1093/clinids/4.supplement_3.s610.

DOI:10.1093/clinids/4.supplement_3.s610
PMID:6218573
Abstract

Concentration-vs.-time curves in serum, peritoneal fluid, bone, and tissue fluid were determined after 2-g intravenous doses of moxalactam. Serum concentrations were measured in five volunteers (group 1; mean age, 22.8 years). Serum and peritoneal fluid concentrations were measured in eight patients (group 2; mean age, 66.5 years). Serum, bone, and tissue fluid concentrations were measured in eight patients (group 3; mean age, 71.5 years). The serum concentrations fitted an open two-compartment model. In groups 1, 2, and 3, the respective serum beta-phase half lives were 134, 169, and 184 min. In group 2, the peak concentration in peritoneal fluid was 43.8 mg/liter after 2.02 hr, with one-quarter of this concentration being maintained for 13 hr. In group 3, the bone concentrations were 19.4 mg/liter after 60 min and 19.1 mg/liter after 120 min; the peak concentration in tissue fluid was 36.1 mg/liter after 2.4 hr, with one-quarter of this concentration being maintained for 15 hr. These concentrations in tissues will inhibit most aerobic and anaerobic bacteria that cause infections.

摘要

静脉注射2克拉氧头孢后,测定血清、腹腔液、骨和组织液中的浓度-时间曲线。在5名志愿者(第1组;平均年龄22.8岁)中测量血清浓度。在8名患者(第2组;平均年龄66.5岁)中测量血清和腹腔液浓度。在8名患者(第3组;平均年龄71.5岁)中测量血清、骨和组织液浓度。血清浓度符合开放二室模型。在第1、2和3组中,各自血清β相半衰期分别为134、169和184分钟。在第2组中,腹腔液中的峰值浓度在2.02小时后为43.8毫克/升,该浓度的四分之一维持13小时。在第3组中,骨浓度在60分钟后为19.4毫克/升,120分钟后为19.1毫克/升;组织液中的峰值浓度在2.4小时后为36.1毫克/升,该浓度的四分之一维持15小时。组织中的这些浓度将抑制大多数引起感染的需氧菌和厌氧菌。

相似文献

1
Distribution of moxalactam in serum, bone, tissue fluid, and peritoneal fluid.羟羧氧酰胺菌素在血清、骨骼、组织液和腹水中的分布。
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S610-6. doi: 10.1093/clinids/4.supplement_3.s610.
2
Moxalactam--absorption, excretion, distribution, and metabolism.
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S569-80. doi: 10.1093/clinids/4.supplement_3.s569.
3
Moxalactam penetration of normal and osteomyelitic bone.
Arch Orthop Trauma Surg (1978). 1983;101(4):273-81. doi: 10.1007/BF00379943.
4
Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.头孢噻肟与拉氧头孢的药代动力学及组织浓度比较。
Antimicrob Agents Chemother. 1980 Sep;18(3):369-71. doi: 10.1128/AAC.18.3.369.
5
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.头孢哌酮、头孢噻肟和拉氧头孢的比较药代动力学
Antimicrob Agents Chemother. 1983 Mar;23(3):429-34. doi: 10.1128/AAC.23.3.429.
6
Absorption, excretion, and clinical efficacy of moxalactam in pediatric patients.羟羧氧酰胺菌素在儿科患者中的吸收、排泄及临床疗效。
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S656-63. doi: 10.1093/clinids/4.supplement_3.s656.
7
Clinical pharmacology of moxalactam in patients with malignant disease.莫西拉坦在恶性疾病患者中的临床药理学。
Antimicrob Agents Chemother. 1981 Apr;19(4):639-44. doi: 10.1128/AAC.19.4.639.
8
Moxalactam kinetics during chronic ambulatory peritoneal dialysis.慢性非卧床腹膜透析期间的头孢氧哌唑动力学
Clin Pharmacol Ther. 1983 Sep;34(3):403-7. doi: 10.1038/clpt.1983.187.
9
Moxalactam epimer kinetics in children.儿童中莫西拉坦差向异构体动力学
Clin Pharmacol Ther. 1982 Apr;31(4):528-32. doi: 10.1038/clpt.1982.71.
10
[The penetration of moxalactam into bone (author's transl)].莫西拉酸在骨组织中的渗透(作者译)
Unfallchirurgie. 1981;7(3):142-6. doi: 10.1007/BF02589729.

引用本文的文献

1
The pharmacokinetics of new cephalosporins: significance in clinical practice.新型头孢菌素的药代动力学:在临床实践中的意义。
Bull N Y Acad Med. 1984 May;60(4):327-39.
2
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
3
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
哌唑嗪最新进展。对其药理特性以及在高血压和充血性心力衰竭治疗中的应用综述。
Drugs. 1983 Apr;25(4):339-84. doi: 10.2165/00003495-198325040-00002.
4
High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.高效液相色谱法测定人血浆和脑脊液中拉氧头孢的含量。
Eur J Clin Pharmacol. 1985;29(2):225-9. doi: 10.1007/BF00547427.